---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-041710"
form_type: "8-K"
ticker: "BBLG"
cik: "0001419554"
company_name: "Bone Biologics Corp"
filed_at: "2024-10-21T23:59:59+00:00"
generated_at: "2026-05-30T12:19:31.058509+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Bone Biologics appoints Phillip Meikle to board, replacing retiring director Don Hankey

## Summary
- Phillip Meikle appointed to Bone Biologics board effective October 16, 2024.
- Meikle founded Biosystems of New England (sold to Stryker in 2019), 30+ years orthopedic/spine experience.
- Don R. Hankey retired from board after seven years of service; board size stays at four.
- Meikle will be compensated in the same manner as other Bone Biologics directors.
- No arrangements or transactions requiring disclosure under Item 404(a) were identified.

## SEC filing metadata
- accession: 0001493152-24-041710
- form_type: 8-K
- ticker: BBLG
- cik: 0001419554
- company_name: Bone Biologics Corp
- filed_at: 2024-10-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1419554/000149315224041710/0001493152-24-041710-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1419554/000149315224041710/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-041710
- JSON: https://secwatch.observer/filing/0001493152-24-041710.json
- Plain text: https://secwatch.observer/filing/0001493152-24-041710.txt

## Key facts
- Executive change
  Phillip Meikle was appointed as Director at Bone Biologics Corp.
  - Action: appointed
  - Role: Director
  source text: On October 16, 2024, the Board of Directors (the “Board”) of Bone Biologics Corporation (the “Company”) appointed Phillip Meikle to the Company’s Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1419554/000149315224041710/0001493152-24-041710-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.